http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-930005988-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-08 |
| filingDate | 1992-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-930005988-A |
| titleOfInvention | Chiral oxazoline |
| abstract | The present invention relates to optically active compounds of the general formula (I) and to liquid crystal mixtures containing such dopants and their use for optical and electroluminescent purposes.n n n n n n n n Wherein n represents 0 or 1; R 3 represents group R 4 or represents a group of the following general formulas (II), (III), (IV) or (V);n n n n n n n n n n n n n A 1 , A 2 and A 3 , independently of one another, are unsubstituted or mono- or polysubstituted with halogen, cyano and / or methyl, in which case one or two CH groups can be optionally substituted with nitrogen. 1,4-phenylene or trans-1,4-cyclohexylene, trans-1,3-dioxane-2,5-diyl, bicyclo [2,2,2] octane-1,4 -Diyl, naphthalene-2,6-diyl, tetralin-2,6-diyl or trans-decalin-2,6-diyl, Z 1 and Z 4 are independently of each other, a single covalent bond or -CH 2 CH 2- ; Z 2 and Z 3 are, independently from each other, a single covalent bond or -CH 2 CH 2- , -COO-, -OOC-, -CH 2 O-, -OCH 2- , -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3 -or -CH = CH-CH 2 CH 2- , -CH 2 CH 2 -CH = CH-, -CH = CH-CH 2 O- or —O—CH 2 —CH═CH— represents a trans form; R 1 and R 5 independently of one another represent C 1 -C 12 alkyl, C 2 -C 12 alkoxymethyl, p-alkoxyphenyl or p-alkoxybenzyl; R 2 and R 6 independently of one another represent hydrogen, C 1 -C 12 alkyl or phenyl; R 7 and R 8 independently of one another represent hydrogen, C 1 -C 12 alkyl, phenyl or C 2 -C 12 alkoxycarbonyl, provided that R 7 and R 8 do not represent hydrogen at the same time; R 9 represents C 1 -C 9 alkyl or C 2 -C 9 alkenyl, which may be unsubstituted or monosubstituted or polysubstituted with fluorine and in which one —CH 2 — group may be replaced with —O—; R 4 is hydrogen, halogan, cyano, trifluoromethyl, trifluoromethoxy, unsubstituted or mono- or polysubstituted with halogen, cyano and / or methyl, with one methyllan group or two nonadjacent media The silane group represents C 1 -C 12 alkyl or C 2 C 12 alkenyl which may be replaced with —O—, —COO— and / or —OOC-; The oxazoline ring of formula (I) is present in optically active form. |
| priorityDate | 1991-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.